Haplotype distribution and mutations at the PAH locus in Croatia. 1992

I Barić, and D Mardesić, and G Gjurić, and V Sarnavka, and B Göbel-Schreiner, and U Lichter-Konecki, and D S Konecki, and F K Trefz
Department of Pediatrics, University Hospital Rebro, Zagreb, Croatia.

Restriction fragment length polymorphism (RFLP) haplotypes and mutations at the phenylalanine hydroxylase (PAH) locus have been studied in 25 unrelated families from Croatia. The results of RFLP analysis demonstrated that 80% of the mutant alleles were associated with three haplotypes (1, 2 and 4). Eight mutations were detected on the background of six mutant haplotypes, comprising 68% of phenylketonuria (PKU) alleles in Croatia. The mutation in codon 408 was most frequent, as was the haplotype 2 allele with which it was associated. These data are in accordance with formerly published population genetic analyses at the PAH locus, and with studies revealing the molecular basis of the phenotypic heterogeneity of PKU. The codon 281 mutation was more frequent in Croatia than previously observed in other populations.

UI MeSH Term Description Entries
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D010651 Phenylalanine Hydroxylase An enzyme of the oxidoreductase class that catalyzes the formation of L-TYROSINE, dihydrobiopterin, and water from L-PHENYLALANINE, tetrahydrobiopterin, and oxygen. Deficiency of this enzyme may cause PHENYLKETONURIAS and PHENYLKETONURIA, MATERNAL. EC 1.14.16.1. Phenylalanine 4-Hydroxylase,Phenylalanine 4-Monooxygenase,4-Hydroxylase, Phenylalanine,4-Monooxygenase, Phenylalanine,Hydroxylase, Phenylalanine,Phenylalanine 4 Hydroxylase,Phenylalanine 4 Monooxygenase
D010661 Phenylketonurias A group of autosomal recessive disorders marked by a deficiency of the hepatic enzyme PHENYLALANINE HYDROXYLASE or less frequently by reduced activity of DIHYDROPTERIDINE REDUCTASE (i.e., atypical phenylketonuria). Classical phenylketonuria is caused by a severe deficiency of phenylalanine hydroxylase and presents in infancy with developmental delay; SEIZURES; skin HYPOPIGMENTATION; ECZEMA; and demyelination in the central nervous system. (From Adams et al., Principles of Neurology, 6th ed, p952). Biopterin Deficiency,Dihydropteridine Reductase Deficiency Disease,Hyperphenylalaninemia, Non-Phenylketonuric,Phenylalanine Hydroxylase Deficiency Disease,BH4 Deficiency,DHPR Deficiency,Deficiency Disease, Dihydropteridine Reductase,Deficiency Disease, Phenylalanine Hydroxylase,Deficiency Disease, Phenylalanine Hydroxylase, Severe,Dihydropteridine Reductase Deficiency,Folling Disease,Folling's Disease,HPABH4C,Hyperphenylalaninaemia,Hyperphenylalaninemia Caused by a Defect in Biopterin Metabolism,Hyperphenylalaninemia, BH4-Deficient, C,Hyperphenylalaninemia, Tetrahydrobiopterin-Deficient, Due To DHPR Deficiency,Non-Phenylketonuric Hyperphenylalaninemia,Oligophrenia Phenylpyruvica,PAH Deficiency,PKU, Atypical,Phenylalanine Hydroxylase Deficiency,Phenylalanine Hydroxylase Deficiency Disease, Severe,Phenylketonuria,Phenylketonuria I,Phenylketonuria II,Phenylketonuria Type 2,Phenylketonuria, Atypical,Phenylketonuria, Classical,QDPR Deficiency,Quinoid Dihydropteridine Reductase Deficiency,Tetrahydrobiopterin Deficiency,Atypical PKU,Atypical Phenylketonuria,Biopterin Deficiencies,Classical Phenylketonuria,Deficiency, BH4,Deficiency, Biopterin,Deficiency, DHPR,Deficiency, Dihydropteridine Reductase,Deficiency, PAH,Deficiency, Phenylalanine Hydroxylase,Deficiency, QDPR,Deficiency, Tetrahydrobiopterin,Disease, Folling,Disease, Folling's,Hyperphenylalaninemia, Non Phenylketonuric,Non Phenylketonuric Hyperphenylalaninemia,Non-Phenylketonuric Hyperphenylalaninemias
D012150 Polymorphism, Restriction Fragment Length Variation occurring within a species in the presence or length of DNA fragment generated by a specific endonuclease at a specific site in the genome. Such variations are generated by mutations that create or abolish recognition sites for these enzymes or change the length of the fragment. RFLP,Restriction Fragment Length Polymorphism,RFLPs,Restriction Fragment Length Polymorphisms
D003062 Codon A set of three nucleotides in a protein coding sequence that specifies individual amino acids or a termination signal (CODON, TERMINATOR). Most codons are universal, but some organisms do not produce the transfer RNAs (RNA, TRANSFER) complementary to all codons. These codons are referred to as unassigned codons (CODONS, NONSENSE). Codon, Sense,Sense Codon,Codons,Codons, Sense,Sense Codons
D006239 Haplotypes The genetic constitution of individuals with respect to one member of a pair of allelic genes, or sets of genes that are closely linked and tend to be inherited together such as those of the MAJOR HISTOCOMPATIBILITY COMPLEX. Haplotype
D000483 Alleles Variant forms of the same gene, occupying the same locus on homologous CHROMOSOMES, and governing the variants in production of the same gene product. Allelomorphs,Allele,Allelomorph
D017523 Croatia Created 7 April 1992 as a result of the division of Yugoslavia.

Related Publications

I Barić, and D Mardesić, and G Gjurić, and V Sarnavka, and B Göbel-Schreiner, and U Lichter-Konecki, and D S Konecki, and F K Trefz
January 2001, Human heredity,
I Barić, and D Mardesić, and G Gjurić, and V Sarnavka, and B Göbel-Schreiner, and U Lichter-Konecki, and D S Konecki, and F K Trefz
January 2004, Genetics, selection, evolution : GSE,
I Barić, and D Mardesić, and G Gjurić, and V Sarnavka, and B Göbel-Schreiner, and U Lichter-Konecki, and D S Konecki, and F K Trefz
November 1990, Human genetics,
I Barić, and D Mardesić, and G Gjurić, and V Sarnavka, and B Göbel-Schreiner, and U Lichter-Konecki, and D S Konecki, and F K Trefz
December 1994, Acta paediatrica (Oslo, Norway : 1992). Supplement,
I Barić, and D Mardesić, and G Gjurić, and V Sarnavka, and B Göbel-Schreiner, and U Lichter-Konecki, and D S Konecki, and F K Trefz
October 1995, Human genetics,
I Barić, and D Mardesić, and G Gjurić, and V Sarnavka, and B Göbel-Schreiner, and U Lichter-Konecki, and D S Konecki, and F K Trefz
January 1992, Human mutation,
I Barić, and D Mardesić, and G Gjurić, and V Sarnavka, and B Göbel-Schreiner, and U Lichter-Konecki, and D S Konecki, and F K Trefz
January 1999, European journal of human genetics : EJHG,
I Barić, and D Mardesić, and G Gjurić, and V Sarnavka, and B Göbel-Schreiner, and U Lichter-Konecki, and D S Konecki, and F K Trefz
August 1991, Human genetics,
I Barić, and D Mardesić, and G Gjurić, and V Sarnavka, and B Göbel-Schreiner, and U Lichter-Konecki, and D S Konecki, and F K Trefz
January 1993, Journal of inherited metabolic disease,
I Barić, and D Mardesić, and G Gjurić, and V Sarnavka, and B Göbel-Schreiner, and U Lichter-Konecki, and D S Konecki, and F K Trefz
February 1992, Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae,
Copied contents to your clipboard!